Trial Details
COMPLETEDBasic Information
| Clinical ID | c919 |
|---|---|
| Identifier | NCT01900574 |
| Trial Title | A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNF Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Golimumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2013-08-09 |
|---|---|
| Primary Completion Date | 2015-02-18 |
| Completion Date | 2022-09-01 |